CareCloud, Inc.
NASDAQ:CCLDMedical - Healthcare Information Services
+$0.04 today
- Market cap
- $101.27M
- Beta
- 1.51
- P/E (TTM)
- 9.7
- EPS (TTM)
- $0.23
Volume 0.53M
Average 0.58M
CCLD Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
CareCloud, Inc.NASDAQ: CCLD
Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Financing cash flow growth accelerates
Q1 FY2026 financing cash flow of $2.15M (cash outflow) rose 11.3% year over year, ahead of the -50.7% change in trailing-twelve-month financing cash flow. Sequentially, it fell 68.6% from the prior quarter. Over 3 fiscal years it compounded at -9.8% a year.
Context
- Financing cash flow amounted to 4.7% of revenue in FY2025, down 5.5 pp from a year earlier.
- Financing cash flow grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +11.3% holds above the trailing-twelve-month pace of -50.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (5.61M) USD
- Year-over-year change
- +50.2%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (5.61M) | +50.2% |
| FY2024 | 2024-12-31 | (11.26M) | +15.3% |
| FY2023 | 2023-12-31 | (13.29M) | -73.7% |
| FY2022 | 2022-12-31 | (7.65M) | -1374.0% |
| FY2021 | 2021-12-31 | (519K) | — |
Financing Cash Flow vs competitors
How CCLD compares with its peers on the latest reported figures
- CCLD's LTM Mar 2026 financing cash flow of $5.83M is the smallest of the 10 companies compared; the peer median is $18.76M.
- Its year-over-year change of -50.7% is the 6th highest of 8, against a peer median of +8.7%.
- Financing cash flow amounts to 4.7% of revenue for CCLD, versus a peer median of 54.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
IRDOpus Genetics, Inc. | LTM Mar 2026 | $57.15M | +156.6% | +136.4% | 477.0% |
| LTM Mar 2026 | $49.08M | +8.7% | +182.8% | 955.9% | |
| LTM Mar 2026 | $32.01M | -71.3% | +8.6% | 25.8% | |
| LTM Mar 2026 | $27.62M | — | +7.0% | — | |
| LTM Mar 2026 | $18.76M | +4324.8% | +205.6% | 54.6% | |
TTRXTurn Therapeutics Inc. | LTM Mar 2026 | $13.71M | — | — | — |
| LTM Mar 2026 | $11.87M | -1411.6% | — | 20.9% | |
| LTM Mar 2026 | $11.67M | -10.2% | — | 77.6% | |
| LTM Mar 2026 | $9.64M | +42.3% | +253.4% | 17.2% | |
| LTM Mar 2026 | $5.83M | -50.7% | -9.8% | 4.7% | |
| Peer median (excluding CCLD) | $18.76M | +8.7% | +159.6% | 54.6% | |
Competitors are the stored peer set for CCLD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.84M | 5.43M | (48.67M) | 7.85M | 10.8M |
| Depreciation & Amortization | 16.25M | 15.6M | 17.04M | 16.46M | 16.98M |
| Deferred Income Tax | 289K | 76K | (525K) | 0 | 0 |
| Stock-Based Compensation | 5.4M | 4.91M | 4.89M | 115K | 454K |
| Change in Working Capital | (10.79M) | (4.03M) | (1.11M) | (4.55M) | 454K |
| Accounts Receivables | (1.24M) | 1.82M | 1.55M | (460K) | 346K |
| Inventory | (104K) | 122K | (84K) | (109K) | 67K |
| Accounts Payables | (10.37M) | (6.59M) | (3.26M) | (4.65M) | 1.27M |
| Other Working Capital | 921K | 619K | 682K | 673K | (1.23M) |
| Other Non-Cash Items | (648K) | (842K) | 43.84M | 759K | (120K) |
| Operating Cash Flow | 13.33M | 21.15M | 15.46M | 20.64M | 28.56M |
| Capital Expenditures | (10.56M) | (11.77M) | (11.61M) | (1.7M) | (8.03M) |
| Acquisitions (Net) | (12.58M) | 0 | 0 | 0 | (16.51M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (7.64M) | (9.18M) | (8.55M) | (5.71M) | (3.25M) |
| Investing Cash Flow | (23.15M) | (11.77M) | (11.61M) | (7.41M) | (24.54M) |
| Debt Repayment | 6.88M | (1M) | 1.11M | (10.68M) | 832K |
| Common Stock Issued | 9.17M | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | (579K) | 0 |
| Dividends Paid | (14.44M) | (15.31M) | (14.3M) | 0 | (6.3M) |
| Other Financing Activities | (2.12M) | (2.23M) | (1.52M) | 0 | (148K) |
| Financing Cash Flow | (519K) | (7.65M) | (13.29M) | (11.26M) | (5.61M) |
| Effect of Forex Changes | (254K) | 225K | 469K | (166K) | 57K |
| Net Change in Cash | (10.59M) | 1.96M | (8.97M) | 1.81M | (1.53M) |
| Free Cash Flow | 2.77M | 9.38M | 3.85M | 18.95M | 20.53M |
CareCloud, Inc.
NASDAQ:CCLD
Intrinsic Alpha fair value
Locked
Current Price
$2.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.